Alex Generous, PhD
Science Writer
St. Jude Children's Research Hospital
Alex Generous, PhD, is a scientific writer in the Strategic Communications, Education and Outreach Department at St. Jude Children’s Research Hospital
POSTS By Alex Generous, PhD
Gene editing holds the promise of a sickle cell cure
| May 30, 2023Explore genome editing approaches to cure sickle cell disease.
Learn moreRamilo brings RSV expertise to St. Jude
| Mar 30, 2023Discover Ramilo's plans for St. Jude RSV research.
Learn moreVisualization and analysis tools break down barriers for big data
| Feb 7, 2023St. Jude is at the forefront of creating tools to visualize and analyze genomic data.
Learn moreGenetic predispositions can drive cancer but are not destiny for patients
| Jan 24, 2023Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.
Learn moreChildhood cancer genetics: A legacy of groundbreaking work drives St. Jude forward
| Jan 10, 2023St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.
Learn moreMath test points metastatic breast cancer treatment in the right direction
| Dec 30, 2022St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.
Learn moreNew model mimics progression of pediatric bone marrow failure
| Oct 4, 2022St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.
Learn moreIt’s in the genes: research reveals obstacles on the road to health for cancer survivors
| Sep 7, 2022St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.
Learn moreTwo Years of the Pediatric Translational Neuroscience Initiative
| Sep 1, 2022St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.
Learn moreFive years later: gene therapy for ‘bubble boy’ disease
| May 19, 2022Interim results point to enduring immune function following gene therapy for Infants with ‘bubble boy’ disease
Learn more